Status:
COMPLETED
Transdermal Electroacupuncture for Opioid Detoxification
Lead Sponsor:
Mclean Hospital
Collaborating Sponsors:
Harvard Medical School (HMS and HSDM)
Conditions:
Opioid Dependency
Eligibility:
All Genders
18-59 years
Phase:
PHASE1
PHASE2
Brief Summary
This single-blind, randomized clinical trial tests whether electroacupuncture, provided as an adjunctive treatment, improves outcomes among patients receiving inpatient opioid detoxification from opio...
Detailed Description
Opioid dependence continues to be a major public health concern in the United States, with prescription opioid abuse rapidly becoming one of the nation's biggest drug problems. Although there have bee...
Eligibility Criteria
Inclusion
- Current opioid dependence
- Current buprenorphine detoxification
- 18-59 years of age
- English proficiency
Exclusion
- Acute mania, psychosis, or suicidality
- Cognitive impairments precluding informed consent
- Heart disease or contraindicated heart condition
- Use of pace maker
- History of seizure disorder
- Current detoxification from alcohol or benzodiazepines
- Inability to return to follow-up visits
- For women, pregnancy
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00742170
Start Date
August 1 2007
End Date
January 1 2010
Last Update
October 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Belmont, Massachusetts, United States, 02478